Woolly Mammoth Billionaire Now Engineering War Dogs

Forbes Colombia reveals that the entrepreneur who founded Colossal Biosciences to resurrect the woolly mammoth has redirected the company's genetic-engineering capabilities toward creating "war dogs" for military use. The pivot leverages the same CRISPR and synthetic-biology toolkit developed for de-extinction but applies it to enhancing canine strength, endurance, and sensory acuity for defense contracts.

The article notes this strategic shift aligns with growing Pentagon interest in biotech-enhanced assets and suggests the mammoth headline was always a proof-of-concept for a more lucrative dual-use platform. The billionaire's name is not in the headline, but the company's trajectory from conservation media darling to defense contractor is the core narrative.

For our readers, this illustrates a recurring pattern in deep tech: the flashy, mission-driven narrative attracts talent and early capital, but the sustainable business model often wears a uniform.

Source: El multimillonario de los mamuts lanudos ahora está creando perros de guerra con ingeniería genética — Forbes Colombia (Spanish); in English: "The Woolly Mammoth Billionaire Is Now Creating Genetically Engineered War Dogs"